Coordination of late gene transcription of human cytomegalovirus with viral DNA synthesis: recombinant viruses as potential therapeutic vaccine candidates

Bibliography

• Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci 1998;95:3937-42
   PubMed Web of Science ®Google Scholar
• Kondo K, Kaneshima H, Mocarski ES. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci USA 1994;91:11879-83
   PubMed Web of Science ®Google Scholar
• Kondo K, Xu J, Mocarski ES. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc Natl Acad Sci USA 1996;93:11137-42
   PubMed Web of Science ®Google Scholar
• Fish KN, Britt W, Nelson JA. A novel mechanism for persistence of human cytomegalovirus in macrophages. J Virol 1996;70:1855-62
   Google Scholar
• Fish KN, Depto AS, Moses AV, Growth kinetics of human cytomegalovirus are altered in monocyte-derived macrophages. J Virol 1995;69:3737-43
   Google Scholar
• Ibanez CE, Schrier R, Ghazal P, Human cytomegalovirus productively infects primary differentiated macrophages. J Virol 1991;65:6581-8
   PubMed Web of Science ®Google Scholar
• Lathey JL, Spector SA. Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J Virol 1991;65:6371-5
   PubMed Web of Science ®Google Scholar
• Sinzger C, Plachter B, Grefte A, Tissue macrophages are infected by human cytomegalovirus. J Infect Dis 1996;173:240-5
   PubMed Web of Science ®Google Scholar
• Sinzger C, Grefte A, Plachter B, Fibroblasts, epithelial cells, endothelial cells, and smooth muscle cells are the major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 1995;76:741-50
   PubMed Web of Science ®Google Scholar
• Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991;72:2059-64
   PubMed Web of Science ®Google Scholar
• Ogawa H, Suzutani T, Baba Y, Etiology of severe sensorineural hearing loss in children: independent impact of congenital cytomegalovirus infection and GJB2 mutations. J Infect Dis 2007;195:782-8
   PubMed Web of Science ®Google Scholar
• Morton CC, Nance WE. Newborn hearing screening–a silent revolution. N Engl J Med 2006;354:2151-64
   PubMed Web of Science ®Google Scholar
• Homer EG, Rinaldi A, Nicholl MJ, Preston CM. Activation of herpesvirus gene expression by the human cytomegalovirus protein pp71. J Virol 1999;73:8512-18
   Google Scholar
• Liu B, Stinski MF. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J Virol 1992;66:4434-44
   PubMedGoogle Scholar
• Hofmann H, Sindre H, Stamminger T. Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx. J Virol 2002;76:5769-83
   PubMedGoogle Scholar
• Bresnahan WA, Shenk TE. UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc Natl Acad Sci USA 2000;97:14506-11
   Google Scholar
• Saffert RT, Kalejta RF. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 2006;80:3863-71
   PubMed Web of Science ®Google Scholar
• Isomura H, Stinski MF. The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection. J Virol 2003;77:3602-14
   Google Scholar
• Isomura H, Stinski MF, Kudoh A, Two Sp1/Sp3 binding sites in the major immediate-early proximal enhancer of human cytomegalovirus have a significant role in viral replication. J Virol 2005;79:9597-607
   Google Scholar
• Isomura H, Tsurumi T, Stinski MF. Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication. J Virol 2004;78:12788-99
   PubMed Web of Science ®Google Scholar
• Meier JL, Stinski MF. Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells. J Virol 1997;71:1246-55
   Google Scholar
• Meier JL, Pruessner JA. The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression. J Virol 2000;74:1602-13
   Google Scholar
• Meier JL, Keller MJ, McCoy JJ. Requirement of multiple cis-acting elements in the human cytomegalovirus major immediate-early distal enhancer for viral gene expression and replication. J Virol 2002;76:313-26
   Google Scholar
• Pari GS, Anders DG. Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J Virol 1993;67:6979-88
   PubMed Web of Science ®Google Scholar
• McWatters BJ, Stenberg RM, Kerry JA. Characterization of the human cytomegalovirus UL75 (glycoprotein H) late gene promoter. Virology 2002;303:309-16
   PubMed Web of Science ®Google Scholar
• Winkler M, Rice SA, Stamminger T. UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J Virol 1994;68:3943-54
   PubMedGoogle Scholar
• Kohler CP, Kerry JA, Carter M, Use of recombinant virus to assess human cytomegalovirus early and late promoters in the context of the viral genome. J Virol 1994;68:6589-97
   Google Scholar
• Leach FS, Mocarski ES. Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J Virol 1989;63:1783-91
   Google Scholar
• Depto AS, Stenberg RM. Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis-acting elements and viral trans-acting proteins necessary for promoter activation. J Virol 1992;66:3241-6
   Google Scholar
• Rudolph SA, Stamminger T, Jahn G. Transcriptional analysis of the eight-kilobase mRNA encoding the major capsid protein of human cytomegalovirus. J Virol 1990;64:5167-72
   Google Scholar
• Messerle M, Crnkovic I, Hammerschmidt W, Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci USA 1997;94:14759-63
   PubMed Web of Science ®Google Scholar
• Borst E, Hahn G, Koszinowski UH, Messerle M. Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Eacherichia coli: a new approach for construction of HCMV mutants. J Virol 1999;73:8320-9
   PubMed Web of Science ®Google Scholar
• Isomura H, Stinski MF, Kudoh A, Noncanonical TATA sequence in the UL44 late promoter of human cytomegalovirus is required for the accumulation of late viral transcripts. J Virol 2008;82:1638-46
   Google Scholar
• Isomura H, Stinski MF, Kudoh A, The late promoter of the human cytomegalovirus viral DNA polymerase processivity factor has an impact on delayed early and late viral gene products but not on viral DNA synthesis. J Virol 2007;81:6197-206
   Google Scholar
• Isomura H, Stinski MF, Kudoh A, A cis element between the TATA Box and the transcription start site of the major immediate-early promoter of human cytomegalovirus determines efficiency of viral replication. J Virol 2008;82:849-58
   Google Scholar
• Isomura H, Stinski MF, Murata T, The human cytomegalovirus UL76 gene regulates the level of expression of the UL77 gene. PLoS ONE 2010;5:e11901
   Google Scholar
• Isomura H, Stinski MF, Murata T, The human cytomegalovirus gene products essential for late viral gene expression assemble into pre- replication complexes before viral DNA replication. J Virol 2011;85:6629-44
   PubMed Web of Science ®Google Scholar
• Homa FL, Glorioso JC, Levine M. A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene. Genes Dev 1988;2:40-53
   PubMed Web of Science ®Google Scholar
• Depto AS, Stenberg RM. Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products. J Virol 1989;63:1232-8
   PubMedGoogle Scholar
• Wing BA, Johnson RA, Huang ES. Identification of positive and negative regulatory regions involved in regulating expression of the human cytomegalovirus UL94 late promoter: role of IE2-86 and cellular p53 in mediating negative regulatory function. J Virol 1998;72:1814-25
   Google Scholar
• Chambers J, Angulo A, Amaratunga D, DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol 1999;73:5757-66
   PubMed Web of Science ®Google Scholar
• McCarthy AM, McMahan L, Schaffer PA. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol 1989;63:18-27
   Google Scholar
• Rice SA, Knipe DM. Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27. J Virol 1990;64:1704-15
   Google Scholar
• Sacks WR, Greene CC, Aschman DP, Schaffer PA. Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J Virol 1985;55:796-805
   PubMedGoogle Scholar
• Sandri-Goldin RM. The many roles of the highly interactive HSV protein ICP27, a key regulator of infection. Future Microbiol 2011;6:1261-77
   PubMed Web of Science ®Google Scholar
• Sedlackova L, Perkins KD, Meyer J, Identification of an ICP27-responsive element in the coding region of a herpes simplex virus type 1 late gene. J Virol 2010;84:2707-18
   Google Scholar
• Arumugaswami V, Wu TT, Martinez-Guzman D, ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus. J Virol 2006;80:9730-40
   Google Scholar
• Wong E, Wu TT, Reyes N, Murine gammaherpesvirus 68 open reading frame 24 is required for late gene expression after DNA replication. J Virol 2007;81:6761-4
   Google Scholar
• Wu TT, Park T, Kim H, ORF30 and ORF34 are essential for expression of late genes in murine gammaherpesvirus 68. J Virol 2009;83:2265-73
   Google Scholar
• Perng YC, Qian Z, Fehr AR, The human cytomegalovirus gene UL79 is required for the accumulation of late viral transcripts. J Virol 2011;85:4841-52
   Google Scholar
• Gruffat H, Kadjouf F, Mariame B, Manet E. The epstein-barr virus BcRF1 gene product is a TBP-like protein with an essential role in late gene expression. J Virol 2012;86:6023-32
   Google Scholar
• Sanders RL, Clark CL, Morello CS, Spector DH. Development of cell lines that provide tightly controlled temporal translation of the human cytomegalovirus IE2 proteins for complementation and functional analyses of growth-impaired and nonviable IE2 mutant viruses. J Virol 2008;82:7059-77
   Google Scholar
• Sanders RL, Del Rosario CJ, White EA, Spector DH. Internal deletions of IE2 86 and loss of the late IE2 60 and IE2 40 proteins encoded by human cytomegalovirus affect the levels of UL84 protein but not the amount of UL84 mRNA or the loading and distribution of the mRNA on polysomes. J Virol 2008;82:11383-97
   Google Scholar
• Du G, Dutta N, Lashmit P, Stinski MF. Alternative splicing of the human cytomegalovirus major immediate-early genes affects infectious-virus replication and control of cellular cyclin-dependent kinase. J Virol 2011;85:804-17
   Google Scholar
• Heider JA, Yu Y, Shenk T, Alwine JC. Characterization of a human cytomegalovirus with phosphorylation site mutations in the immediate-early 2 protein. J Virol 2002;76:928-32
   Google Scholar
• Hofmann H, Floss S, Stamminger T. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J Virol 2000;74:2510-24
   PubMedGoogle Scholar
• Lee JM, Kang HJ, Lee HR, PIAS1 enhances SUMO-1 modification and the transactivation activity of the major immediate-early IE2 protein of human cytomegalovirus. FEBS Lett 2003;555:322-8
   Google Scholar
• Stasiak PC, Mocarski ES. Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J Virol 1992;66:1050-8
   Google Scholar
• Romanowski MJ, Garrido-Guerrero E, Shenk T. pIRS1 and pTRS1 are present in human cytomegalovirus virions. J Virol 1997;71:5703-5
   Google Scholar
• Zuccola HJ, Filman DJ, Coen DM, Hogle JM. The crystal structure of an unusual processivity factor, herpes simplex virus UL42, bound to the C terminus of its cognate polymerase. Mol Cell 2000;5:267-78
   PubMed Web of Science ®Google Scholar
• Komazin-Meredith G, Mirchev R, Golan DE, Hopping of a processivity factor on DNA revealed by single-molecule assays of diffusion. Proc Natl Acad Sci USA 2008;105:10721-6
   Google Scholar
• Geballe AP, Leach FS, Mocarski ES. Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol 1986;57:864-74
   PubMedGoogle Scholar
• Ranneberg-Nilsen T, Rollag H, Slettebakk R, The chromatin remodeling factor SMARCB1 forms a complex with human cytomegalovirus proteins UL114 and UL44. PLoS One 2012;7:e34119
   Google Scholar
• Kerry JA, Priddy MA, Jervey TY, D. VC, et al. Multiple regulatory events influence expression of human cytomegalovirus DNA polymerase (UL54) expression during viral infection. J Virol 1996;70:373-82
   Google Scholar
• Sarisky RT, Hayward GS. Evidence that the UL84 gene product of human cytomegalvorus is essential for promoting oriLyt-dependent DNA replication and formation of replication compartments in cotransfection assays. J Virol 1996;70:7398-413
   Google Scholar
• Burkham J, Coen DM, Weller SK. ND10 protein PML is recruited to herpes simplex virus type 1 prereplicative sites and replication compartments in the presence of viral DNA polymerase. J Virol 1998;72:10100-7
   PubMedGoogle Scholar
• Gao M, Knipe DM. Potential role for herpes simplex virus ICP8 DNA replication protein in stimulation of late gene expression. J Virol 1991;65:2666-75
   PubMedGoogle Scholar
• Godowski PJ, Knipe DM. Transcriptional control of herpesvirus gene expression: gene functions required for positive and negative regulation. Proc Natl Acad Sci USA 1986;83:256-60
   PubMedGoogle Scholar
• Zhou C, Knipe DM. Association of herpes simplex virus type 1 ICP8 and ICP27 proteins with cellular RNA polymerase II holoenzyme. J Virol 2002;76:5893-904
   PubMed Web of Science ®Google Scholar
• Taylor TJ, Knipe DM. Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J Virol 2004;78:5856-66
   PubMed Web of Science ®Google Scholar
• Ho CK, Shuman S. Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme. Mol Cell 1999;3:405-11
   PubMed Web of Science ®Google Scholar
• Schroeder SC, Schwer B, Shuman S, Bentley D. Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev 2000;14:2435-40
   PubMed Web of Science ®Google Scholar
• Licatalosi DD, Geiger G, Minet M, Functional interaction of yeast pre-mRNA 3' end processing factors with RNA polymerase II. Mol Cell 2002;9:1101-11
   PubMed Web of Science ®Google Scholar
• Komarnitsky P, Cho EJ, Buratowski S. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev 2000;14:2452-60
   PubMed Web of Science ®Google Scholar
• Dai-Ju JQ, Li L, Johnson LA, Sandri-Goldin RM. ICP27 interacts with the C-terminal domain of RNA polymerase II and facilitates its recruitment to herpes simplex virus 1 transcription sites, where it undergoes proteasomal degradation during infection. J Virol 2006;80:3567-81
   Google Scholar
• Tran K, Mahr JA, Spector DH. Proteasome subunits relocalize during human cytomegalovirus infection, and proteasome activity is necessary for efficient viral gene transcription. J Virol 2010;84:3079-93
   PubMedGoogle Scholar
• Tamrakar S, Kapasi AJ, Spector DH. Human cytomegalovirus infection induces specific hyperphosphorylation of the carboxyl-terminal domain of the large subunit of RNA polymerase II that is associated with changes in the abundance, activity, and localization of cdk9 and cdk7. J Virol 2005;79:15477-93
   PubMedGoogle Scholar
• Strang BL, Boulant S, Coen DM. Nucleolin associates with the human cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for efficient viral replication. J Virol 2010;84:1771-84
   Google Scholar
• Strang BL, Boulant S, Kirchhausen T, Coen DM. Host cell nucleolin is required to maintain the architecture of human cytomegalovirus replication compartments. MBio 2012;3(1):e00301-11
   Google Scholar
• Zhang LF, Wang YT, Tian JH, Preemptive versus prophylactic protocol to prevent cytomegalovirus infection after renal transplantation: a meta-analysis and systematic review of randomized controlled trials. Transpl Infect Dis 2011;13:622-32
   PubMedGoogle Scholar
• Einsele H, Ehninger G, Hebart H, Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995;86:2815-20
   PubMed Web of Science ®Google Scholar
• Goodrich JM, Mori M, Gleaves CA, Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med 1991;325:1601-7
   PubMed Web of Science ®Google Scholar
• Ljungman P, Hakki M, Boeckh M. Cytomegalovirus in hematopoietic stem cell transplant recipients. Infect Dis Clin North Am 2010;24:319-37
   PubMed Web of Science ®Google Scholar
• Lilleri D, Gerna G, Fornara C, Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. Blood 2006;108:1406-12
   PubMed Web of Science ®Google Scholar
• Boeckh M, Leisenring W, Riddell SR, Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003;101:407-14
   PubMed Web of Science ®Google Scholar
• Rutella S, Locatelli F. Strategies to harness immunity against infectious pathogens after haploidentical stem cell transplantation. Am J Transl Res 2011;3:404-21
   Google Scholar
• Emery VC, Sabin CA, Cope AV, Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000;355:2032-6
   PubMed Web of Science ®Google Scholar
• Nakamura R, Battiwalla M, Solomon S, Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure. Biol Blood Marrow Transplant 2004;10:49-57
   PubMedGoogle Scholar
• Gyulai Z, Endresz V, Burian K, Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs. J Infect Dis 2000;181:1537-46
   PubMed Web of Science ®Google Scholar
• Sylwester AW, Mitchell BL, Edgar JB, Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005;202:673-85
   PubMed Web of Science ®Google Scholar
• Griffiths PD, Stanton A, McCarrell E, Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet 2011;377:1256-63
   PubMed Web of Science ®Google Scholar
• Kharfan-Dabaja MA, Boeckh M, Wilck MB, A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis 2012;12:290-9
   PubMed Web of Science ®Google Scholar
• Genini E, Percivalle E, Sarasini A, Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections. J Clin Virol 2011;52:113-18
   PubMed Web of Science ®Google Scholar
• Boursnell ME, Entwisle C, Blakeley D, A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. J Infect Dis 1997;175:16-25
   PubMed Web of Science ®Google Scholar